XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2019       62,574,961                
Beginning balance at Dec. 31, 2019 $ 1,782,485 $ (34) $ 1,782,451 $ 626 $ 626 $ 1,348,733 $ 1,348,733 $ 433,126 $ (34) $ 433,092 $ 0 $ 0
Stockholders' Equity [Roll Forward]                        
Net Income 367,582             367,582        
Shares issued under stock-based compensation programs, net (in shares)       2,278,020                
Shares issued under stock-based compensation programs, net 28,825     $ 23   28,802            
Cash dividends declared (89,008)             (89,008)        
Stock-based compensation expense 30,062         30,062            
Forfeiture of restricted stock (in shares)       (1,855)                
Forfeiture of restricted stock 0                      
Ending balance (in shares) at Dec. 31, 2020       64,851,126                
Ending balance at Dec. 31, 2020 2,119,912     $ 649   1,407,597   711,666     0  
Stockholders' Equity [Roll Forward]                        
Net Income 573,657             573,657        
Shares issued under stock-based compensation programs, net (in shares)       640,869                
Shares issued under stock-based compensation programs, net (16,216)     $ 6   (16,222)            
Cash dividends declared (117,842)             (117,842)        
Stock dividends declared (in shares)       5,192,776                
Stock dividend declared (687)     $ 52   279,579   (280,318)        
Stock-based compensation expense 38,322         38,322            
Forfeiture of restricted stock (in shares)       (16,678)                
Forfeiture of restricted stock $ 0                      
Ending balance (in shares) at Dec. 31, 2021 70,668,093     70,668,093                
Ending balance at Dec. 31, 2021 $ 2,597,146     $ 707   1,709,276   887,163     0  
Stockholders' Equity [Roll Forward]                        
Net Income 562,139             562,139        
Shares issued under stock-based compensation programs, net (in shares)       1,931,633                
Shares issued under stock-based compensation programs, net 16,840     $ 19   16,821            
Cash dividends declared (142,417)             (142,417)        
Stock-based compensation expense 58,076         58,076            
Forfeiture of restricted stock (in shares)       (14,130)                
Forfeiture of restricted stock $ 0                      
Ending balance (in shares) at Dec. 31, 2022 72,585,596     72,585,596                
Ending balance at Dec. 31, 2022 $ 3,091,784     $ 726   $ 1,784,173   $ 1,306,885     $ 0